(Q36698647)

15 August 2017

1 reference

title

Negative symptoms of schizophrenia: a problem that will not go away (English)

1 reference

15 August 2017

0 references

Stahl SM

1

1 reference

15 August 2017

Buckley PF

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Acta Psychiatrica Scandinavica

15 August 2017

published in

1 reference

15 August 2017

volume

115

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

4-11

1 reference

The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Treatment of schizophrenia negative symptoms: future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

An industry perspective on the NIMH consensus statement on negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The NIMH-MATRICS consensus statement on negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Finding what you are not looking for: strategies for developing novel treatments in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The evolving concept of schizophrenia: from Kraepelin to the present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The heterogeneity of the long-term course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The structure of negative symptoms within schizophrenia: implications for assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Negative symptoms and cognitive deficits: what is the nature of their relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Subdomains within the negative symptoms of schizophrenia: commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Investigating the neurodevelopmental hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2006.00947.X

10.1111/J.1600-0447.2006.00947.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference